Sinopharm
1099.HK
#2002
Rank
C$11.23 B
Marketcap
$3.60
Share price
-2.43%
Change (1 day)
2.70%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

EPS for Sinopharm (1099.HK)

EPS in 2022: $0.55

According to Sinopharm's latest financial reports the company's current EPS (TTM) is $0.55. In 2022 the company made an earnings per share (EPS) of $0.55 an increase over its 2021 EPS that were of $0.55.

EPS history for Sinopharm from 2006 to 2022

Annual EPS

Year EPS Change
2022$0.551.3%
2021$0.5510.33%
2020$0.5017.26%
2019$0.425.44%
2018$0.40-0.87%
2017$0.4019.44%
2016$0.3415.3%
2015$0.2917.06%
2014$0.2521.9%
2013$0.2111.82%
2012$0.1825.24%
2011$0.1531.02%
2010$0.113.3%
2009$0.1146.85%
2008$0.0738767.57%
2007$0.04408310.24%
2006$0.01075